Company
United StatesPublic company, NYSE: MDTMedtronic, Inc. (NYSE: MDT), Bellevue, WA – FDA Inspections
Inspection records and compliance data for Medtronic, Inc. in Bellevue, Washington. 1 FDA inspection on record, last inspected January 24, 2013. Publicly traded as NYSE: MDT.
Company Profile
This profile covers Medtronic, Inc. based in Bellevue, Washington, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected January 24, 2013.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 24, 2013 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 815429 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Medtronic, Inc.
Stock ticker
MDT
Exchange
NYSE
Share price
$105.03
Market cap
$134.3B
Price as of
November 6, 2026
FEI Number
3004612291
Address
11808 Northup Way Ste W300, Bellevue, Washington 98005, United States
Country
United States
ID: c42f5131-548d-43c1-be31-ed16432b574c